What HistoWiz does

HistoWiz is a contract research organization (CRO) that provides automated histopathology and digital pathology services to biomedical researchers, founded around 2012-2013 and headquartered in Long Island City, New York. The company combines a physical histology laboratory with a cloud-based digital pathology platform called PathologyMap, digitizing every stained slide via whole slide imaging and hosting the largest preclinical data collection cited in the company's positioning — over 2 million whole slide images produced and 700,000+ active images serving 7,000+ users across 550+ organizations. Service offerings include precision histology (H&E, special stains) with 3-day turnaround, immunostaining with 400+ validated antibodies, multiplex immunofluorescence (Akoya PSP, CST SignalStar, Cell IDx, Ultivue InSituPlex), slide archiving, block management with 24-hour retrieval, on-demand telepathology consultation through 135+ board-certified pathologists across 88+ specialties, and quantitative image analysis.

The core technology stack is PathologyMap 2.0, a cloud-based platform that added AI-powered automated tissue segmentation and quality control (98%+ accuracy) in June 2024, integrating third-party AI tools from AIRA Matrix and supporting universal slide format ingestion (SVS, CZI, TIFF, QPTIFF, NDPI, OME-TIFF). In 2024 the company also introduced GLP-compliant histology workflows, a Digital Block Management solution, and spatial multiomics/ISH services. Revenue is generated primarily through quote-based project pricing for professional services, supplemented by subscription/recurring access to the PathologyMap platform and a pay-per-use AI apps library; pricing is not publicly disclosed. Go-to-market is hybrid: a self-serve online platform (app.histowiz.com) with integrated FedEx shipping, a field sales team for enterprise pharma accounts, and a regional Champion Program dropbox network across the New York Metro Area that has processed 50,000+ samples. HistoWiz is a privately held, venture-backed company, having raised a $32.25 million Series A in October 2021 led by Vivo Capital with Asahi Kasei and venBio Partners. The company serves both pharmaceutical/biotech clients (GSK, Boehringer Ingelheim, Takeda, Johnson & Johnson) and academic medical centers (Stanford, MSKCC, Fred Hutchinson, Dana-Farber, University of Pennsylvania), with CEO Linh Hoang leading as of end of 2024.

Name

HistoWiz

Legal name

HistoWiz, Inc.

Website

https://home.histowiz.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

51–100 employees

Short description

HistoWiz provides automated histopathology and digital pathology services to biomedical researchers, combining a cloud-based whole slide imaging platform (PathologyMap 2.0) with GLP-compliant histology, immunostaining, multiplex IF, and on-demand pathology consultation for pharma, biotech, and academic clients.

Ownership category

akta.pro rank

Product category

Histopathology Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Pathology & Histopathology Services (HLAGAFAI)

akta.pro secondary industries

Anatomic Pathology & Histopathology (Trial Support) (HLAGAEAC), Medical Imaging AI (HDAAAEAH), Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays) (HLAAALAO), Molecular Pathology & Tissue Biomarkers (IHC/ISH, digital pathology-linked markers) (HLAAAMAI)

Keywords

• Histopathology services
• Digital pathology platform
• Tissue slide imaging
• Immunohistochemistry staining
• Quantitative image analysis

Headquarters

HQ city

Brooklyn

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. Histology Services: Precision histology services including tissue processing, slide generation, H&E staining, special stains. Turnaround time as fast as 3 days. GLP and non-GLP services available.
2. Immunostaining Services: Advanced IHC and IF staining for protein visualization with 400+ validated antibodies. Includes multiplex immunofluorescence (mIF) services.
3. Digital Pathology Platform (PathologyMap): Cloud-based platform for slide viewing, data management, collaboration and analysis. Hosts the largest collection of preclinical data for AI-driven and QC tools.
4. Slide Archiving and Storage: Digitization and storage of glass slide collections with high-throughput scanning for virtually every tissue type. Block storage services with 24-hour retrieval.
5. Path Consult (Telepathology): Online, on-demand consultation with 100+ board-certified pathologists. Network includes toxicology pathologists for GLP pathology consultations.
6. Quantitative Image Analysis: Expert-led image analysis services providing objective assessments using HALO, Visopharm, QuPath, and proprietary AI tools.
7. AI Apps (Pay-per-use): AI-powered analysis tools accessible through PathologyMap platform with pay-per-use pricing model - no extra software setup or subscription fees.
8. Multiomics/ISH: Spatial multiomics services combining RNA-ISH with protein detection, experienced on 100+ customized developmental projects.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Core offering

HistoWiz provides automated histopathology services for biomedical researchers, converting tissue specimens into high-quality digital slides in as few as 3 days. The company delivers precision histology, IHC/IF immunostaining with 400+ validated antibodies, slide archiving, telepathology consultation with board-certified pathologists, quantitative image analysis, and multiomics/ISH services. Its cloud-based PathologyMap platform hosts the largest collection of preclinical whole slide images and offers AI-powered tissue segmentation and quality control.

Differentiator

Problem solved

Functional benefit

Brands

• PathologyMap™: Cloud-based digital pathology platform for whole slide imaging, AI-powered analysis, data management, collaboration, and quality control for histopathology research.
• PathologyMap 2.0
• Path Consult
• Block Manager

Products and services

• Precision Histology High-quality tissue processing, embedding, sectioning, and slide generation for biomedical researchers, available in both GLP and non-GLP compliant workflows with turnaround times as fast as 3 days.
• Immunostaining Advanced immunohistochemistry (IHC) and immunofluorescence (IF) staining using 400+ validated antibodies, including multiplex immunofluorescence (mIF) for up to 9 channels, serving protein visualization needs in research samples.
• Slide Archiving Digitization of glass slide collections via high-throughput whole slide imaging (WSI) scanning for virtually every tissue type, with images stored on the cloud-based PathologyMap platform.
• Path Consult (Telepathology) Online, on-demand consultation service connecting researchers with 100+ board-certified pathologists across over 88 specialties, including toxicology pathologists for GLP pathology consultations.
• Quantitative Image Analysis Expert-led image analysis using HALO, Visopharm, QuPath, and proprietary AI tools for cell segmentation, biomarker quantification, tumor detection, and region of interest classification.
• Multiomics / ISH Spatial multiomics services combining HCR RNA-ISH with multiplex IF for simultaneous detection of transcribed RNA and translated protein on one slide, including Akoya PSP (up to 6 markers), CST SignalStar, Cell IDx, and Ultivue InSituPlex (up to 12 markers).
• PathologyMap Platform Cloud-based digital pathology platform for slide viewing, data management, collaboration, and AI-powered analysis. Hosts 700,000+ active whole slide images, supports universal image format upload (SVS, CZI, TIFF, QPTIFF, NDPI, OME-TIFF), and includes an AI Apps library with pay-per-use pricing.
• Block Manager Digital block management solution providing 24/7 access to FFPE research samples with real-time tracking, 24-hour retrieval time, and integrated histology services for streamlined workflows.

Quantifiable outcome

• 3-day turnaround time from tissue specimens to high-quality digital slides
• +4 more outcomes

Named customers9 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability4 records

Feature12 records

Partnerships

Nine partnerships are on record, tiered core and flagship.

• AIRA MatrixcoreTechnology or IntegrationAI tool integration partnership where AIRA Matrix's digital pathology AI tools are integrated into HistoWiz's PathologyMap platform, making them available to pharma, biotech and academic institutions globally. PathologyMap achieves over 98% accuracy in automated quality control for pathology slides using these integrated AI tools.
• Akoya BiosciencesflagshipStrategic or Co-development PartnerFirst organization to partner with Akoya in developing the PSP (Phenocode Signature Panels) platform for multiplex immunofluorescence. Offers up to 6 markers within a single tissue section with 10-day turnaround time. Provides researchers with rapid, detailed insights into complex tissue samples.
• Akoya Biosciences (Qualified CRO Service Provider)coreTechnology or IntegrationProud member of Akoya's qualified CRO service provider network, demonstrating expertise in multiplex immunofluorescence workflows and adherence to Akoya's quality standards.
• Leica MicrosystemscoreTechnology or IntegrationUses Leica Bond RX automated stainer for all staining procedures, following Standard Operating Procedures and fully automated workflow for consistent, high-quality results.
• Indica Labs (HALO)coreTechnology or IntegrationUses HALO image analysis software as primary tool for automated quantitative image analysis, providing objective assessments of staining intensity and tissue characteristics.
• VisiopharmcoreTechnology or IntegrationUses Visiopharm image analysis software alongside HALO for quantitative image analysis services, providing additional options for biomarker quantification and tissue classification.
• QuPathcoreTechnology or IntegrationUses QuPath (open-source) for image analysis in addition to commercial solutions, providing flexibility for different analysis requirements.
• ACD (Advanced Cell Diagnostics)coreTechnology or IntegrationPriority probe development partner for in situ hybridization (ISH) services. Provides access to ACD's RNA detection technologies for spatial transcriptomics applications.
• Molecular Instruments (HCR)coreTechnology or IntegrationPartnership for HCR (Hybridization Chain Reaction) RNA-ISH platform, enabling simultaneous detection of transcribed RNA and translated protein on one slide. On-demand webinar collaboration for customer education.

Scale indicators15 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• PathAI: AI-powered digital pathology platform serving pharma, biotech, and academic clients with both services and software. Most direct competitor in the AI-enabled preclinical/clinical pathology space, with overlapping customer base and similar focus on data-driven tissue analysis.
• Flagship Biosciences: Tissue image analysis CRO specializing in quantitative pathology, IHC/IF, and digital slide services for pharma/biotech preclinical and clinical programs. Direct peer in the regulated histology + image analysis service offering.
• IONpath: Provider of multiplex spatial biology services (MIBI technology) and digital pathology for translational and clinical research. Overlaps with HistoWiz in multiplex IF, IHC services, and pathology image analysis for oncology/immunology research.
• Indica Labs: Developer of HALO image analysis software used widely for digital pathology quantification. Both partner and competitor — HistoWiz uses HALO for IA services while Indica also sells directly to pharma and academic customers in the same workflow.
• Visiopharm: Quantitative image analysis software provider for digital pathology with significant pharma/biotech adoption. Competes with HistoWiz in biomarker quantification, tissue classification, and AI-driven image analysis services.

Emerging players

• Akoya Biosciences: Multiplex immunofluorescence platform company (OPAL/PhenoCode) with whom HistoWiz has a Flagship co-development partnership. Comparable in multiplex IF services for translational research but operates more as an instrument/reagent vendor with growing CRO offerings.
• Canopy Biosciences (Bruker): Spatial biology services provider offering multiplex IF, spatial transcriptomics, and digital pathology services to pharma and academic clients. Comparable service catalog for translational and preclinical research customers.

Broad incumbents

• Charles River Laboratories: Global CRO offering preclinical histology, toxicology pathology, and GLP-compliant services. Far larger scale and broader service menu; competes with HistoWiz for pharma preclinical histology spend but does not focus on the academic/PLG segment.
• WuXi AppTec: Large preclinical CRO with integrated histology, toxicology, and bioanalysis services for global pharma/biotech. Competes for enterprise pharma histology contracts at large scale.
• Leica Biosystems (Danaher): Provider of histology instruments, Aperio whole slide imaging scanners, and digital pathology software. Overlaps in WSI infrastructure and downstream pathology workflow; HistoWiz depends on Leica Bond RX stainer while Leica/Aperio competes on enterprise digital pathology platforms.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/HistoWiz
• LinkedInlinkedin.com/company/histowiz

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds6 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HistoWiz